Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin for cerebral oxygenation in liver transplantation
NCT03395574Phase 2Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jan 2018
- Primary completion
- Nov 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terlipressin in liver transplantation, sponsored by Kasr Al Ainy Hospital. Started Jan 2018; status: completed.
02
Drugs
terlipressin
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT03395574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03395574.